SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-023674
Filing Date
2022-06-21
Accepted
2022-06-21 08:00:17
Documents
12
Period of Report
2022-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K prld-8k_20220617.htm   iXBRL 8-K 46716
  Complete submission text file 0001564590-22-023674.txt   175541

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA prld-20220617.xsd EX-101.SCH 5577
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20220617_lab.xml EX-101.LAB 19308
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20220617_pre.xml EX-101.PRE 11474
6 EXTRACTED XBRL INSTANCE DOCUMENT prld-8k_20220617_htm.xml XML 3550
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 221026082
SIC: 2834 Pharmaceutical Preparations